|
Recent Developments |
|
19-OCT-11
RPG Life Sciences has posted a net profit of Rs 20.7 million for the quarter ended Sept. 30, 2011 as compared to Rs 39.1 million for the quarter ended Sept. 30, 2010, reflecting decrease of 47.06%.
07-OCT-11
Credit rating agency, ICRA has assigned BBB+ to Rs. 23.7 crores1 term loan and Rs 337 million fund based limits of RPG Life Sciences. ICRA has also assigned A2 to Rs 309 million non-fund based bank limits of RPG Life Sciences (RP... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2012(9) | 31-Mar-2012 (12) | 31-Mar-2011 (12) | | Net sales | 1598.70 | 1892.30 | 1841.90 | | Other Income | 8.80 | 6.90 | 0.20 | | Total Income | 1607.50 | 1899.20 | 1842.10 | | Cost of goods sold | 1543.80 | 1746.70 | 1547.60 | | OPBDIT | 63.70 | 152.50 | 294.50 | | PAT | -29.90 | 8.50 | 127.10 | | Gross Block | - | - | - | | Equity capital | 132.30 | 132.30 | 132.30 | | EPS (Rs.) | - | 0.51 | 8.04 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 111.76 - 181.86 | 7.74 - 15.17 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 4.0 | 8.0 | 16.0 | | Net margin (% of OI) | -1.9 | 0.4 | 6.9 |
|
|
Detailed Financials
|
|
|
|
|
Snapshot
